Grand Pharmaceutical Group Limited's total assets for Q2 2025 were HK$26.47B, an increase of 5.91% from the previous quarter. HK:0512 total liabilities were HK$9.18B for the fiscal quarter, a 8.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.